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A B S T R A C T
This study evaluated brain natriuretic peptide (BNP) release in acute myocardial infarction (AMI), absolute values as
well as pattern of its release. There are two different patterns of BNP release in AMI; monophasic pattern – concentration in
the first measurement is higher than in the second one, and biphasic pattern – concentration in the first measurement is
lower than in the second one. We observed significance of biphasic and monophasic pattern of BNP release related to diag-
nostic and prognostic value. We included in this prospective observational study total of 75 AMI patients, 52 males and 23
females, average age of 62.3±10.9 years with range of 42 to 79 years. BNP was measured and pattern of its release was
evaluated. In AMI group BNP levels were significantly higher than in controls (462.88 pg/mL vs. 35.36 pg/mL, p<0.001).
We found statistically significant real negative correlation (p<0.05) between BNP concentration and left ventricle ejection
fraction (LVEF) with high correlation coefficient (r=–0.684). BNP concentrations were significantly higher among patients
in Killip class II and III compared to Killip class I; Killip class I BNP=226.18 pg/mL vs. Killip class II 622.51 pg/mL vs.
Killip class III 1530.28 pg/mL, p<0.001. BNP concentrations were significantly higher in patients with; (i) myocardial in-
farction vs. controls; (BNP 835.80 pg/mL vs. 243.03 pg/mL); (ii) in pts with positive major adverse cardiac events (MACE)
vs. negative MACE (BNP 779.08 pg/mL vs. 242.28 pg/mL, p<0.001); (iii) in pts with positive compared to negative left ven-
tricle (LV) remodelling (BNP 840.77 pg/mL vs. 341.41 pg/mL, p<0.001). Group with biphasic pattern of BNP release had
significantly higher BNP concentration compared to monophasic pattern group. In biphasic pattern group we found signif-
icant presence of lower LVEF, Killip class II and III, LV remodelling and MACE. We found that BNP is strong marker of
adverse cardiac events in patients presenting with a myocardial infarction. In our AMI group we found significant eleva-
tion of BNP and it is suspected that second peak secretion is not only due to systolic dysfunction and subsequent remodeling
of LV but also due to impact of ischaemia. Patients with biphasic pattern probably have worse prognosis due to severe coro-
nary heart disease. Besides its diagnostic role as a simple blood marker of systolic function, BNP is also important prog-
nostic marker who helps making clinical decision about early invasive vs. conservative management.
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Introduction
Brain natriuretic peptide (BNP) is cardiac hormone
and acts as a marker of ventricular function. Primary
cause of brain natriuretic peptide secretion is stretching,
volume overload and high filling pressure of ventricle.
Secretion of BNP is part of activated compensatory mecha-
nisms in heart failure syndrome. Many clinical and epide-
miological studies showed direct correlation of BNP and
lower left ventricle ejection fraction (LVEF)1,2. Study of
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Maisel et al.3 was first multicentre prospective study
which used BNP in evaluation of dyspnoea making possi-
ble differentiation of cardiac and pulmonary dyspnoea.
Recent studies have found that elevation of BNP in
AMI is not only a simple consequence of reduced global
systolic function (high wall stress) – it seems that ischae-
mia per se induces de novo BNP secretion4,5.
Other studies6–8 have confirmed higher level of BNP
as a strong and independent prognostic parameter in
acute ischaemic events besides traditional i.e. old risk
factors9–11. Antman and Braunwald11 found that in AMI
BNP was released in circulation early so that first peak
occurs about 16 hours after beginning of symptoms. In
patients with anteroseptal AMI, lower LVEF and symp-
toms of heart failure there is a second peak in BNP release
about 5th to 7th day from the beginning of symptoms11.
BNP in AMI shows two different pattern of release: (i)
monophasic pattern – concentration in the first measure-
ment is higher than in the second one), (ii) biphasic pat-
tern – concentration in the first measurement is lower
than in the second one.
BNP level is increased in AMI and its rise shows cor-
relation with LV systolic dysfunction. We performed this
study to evaluate significance of biphasic and monopha-
sic pattern of BNP release related to diagnostic and prog-
nostic value.
Methods
In AMI group were involved 75 patients, their blood
samples for analysis of BNP were taken during first 48h
i.e. 1st to 2nd day (first measurement) and from 5th to 8th
day of hospitalisation (second measurement). LVEF was
calculated before discharge by echocardiography and signs
of ventricular remodelling were also registered. Major
adverse cardiac events; repeated chest pain, reinfarction,
heart failure, ventricular arrhythmias and sudden car-
diac death were registered. Structure of control group
(n=61) was similar by age and gender to AMI group but
without arterial hypertension and coronary heart disease
and with normal echocardiography.
Data are expressed as a X±SEM or median and inter-
val. For parametric variables not belonging to the same
population Student t-test was used while for nonpa-
rametric variables we used c2-test. Mann-Whitney U-test
is a test for assessing whether two of observations come
from the same distribution. Pearson correlation test was
used to assess association between measured parame-




Brain natriuretic peptide was observed in 75 patients
with acute myocardial infarction, 52 males and 23 fema-
les, average age of 62.3±10.9 years with range of 42 to 79
years. The baseline characteristics of the study patients
are provided in Table 1.
BNP levels and left ventricle ejection fraction
BNP concentration rises proportionally as LVEF low-
ers in AMI group. Patients with significant decrease of
systolic function had the highest BNP levels, while pa-
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TABLE 1
AMI GROUP – AGE AND GENDER
AMI group Males Females Total
N 52 23 75
X 60.596 66.130 62.293
SD 10.776 10.494 10.926
SEM 1.494 2.188 1.262
Median 57.5 66 63
Interval (yrs) 42–79 45–79 42–79
p<0.05


















Fig. 1. Correlation of BNP and LVEF.
tients with normal systolic function had the lowest BNP
levels. Patients with LVEF <30% – BNP 1129.03 pg/mL,
patients with LVEF 31–40% – BNP 690.17 pg/mL, pa-
tients with LVEF 41–50% – BNP 274.39 pg/mL, and pa-
tients with LVEF >51% – BNP 189.56 pg/mL, signifi-
cance of p<0.001.
Test of correlation showed statistically significant real
negative correlation (p<0.05) between BNP concentra-
tion and decrease of LVEF with high correlation coeffi-
cient (r=–0.684) (Figure 1).
BNP in heart failure
BNP concentrations were significantly higher among
patients in Killip class II and Killip class III compared to
those of Killip class I. We found gradual increase in BNP
levels from Killip class I to Killip class III as follows; BNP
226.18 pg/mL, 622.50 pg/mL, 1530.27, significance of
p<0.001.
BNP and MACE
We evaluated BNP levels in patient with MACE and
found that patients with complications in intrahospital
period had significantly higher BNP levels, MACE posi-
tive vs. MACE negative; BNP 779.07 pg/mL vs. 242.28
pg/mL, significance of p<0.001.
Pattern of BNP release
Group with biphasic pattern of BNP release has sig-
nificantly higher BNP concentration in first measure-
ment (BNP 1 – first measurement in the 1st to 2nd day of
admission) and second measurements (BNP 2 – second
measurement in the 5th to 8th day of admission) com-
pared to group with monophasic pattern (Table 2).
In biphasic pattern group compared to monophasic
group left ventricle ejection fraction was significantly
lower compared to monophasic pattern group; LVEFbi-
phasic=36.26% vs. LVEFmonophasic=48.07%, significan-
ce of p<0.001.
In biphasic pattern group compared to monophasic
group we found significantly more patients with antero-
septolateral AMI compared to other allocations of AMI;
monophasic pattern (1 pt) vs. biphasic pattern (14 pts), sig-
nificance p<0.001). Other allocations of AMI; inferior AMI,
apical AMI, inferoposterior AMI had significantly more
patients with monophasic pattern of BNP (Table 3).
In biphasic pattern group compared to monophasic
group were significantly more patients with Killip class
II and Killip class III, while in Killip class I there were
significantly more patients with monophasic BNP pat-
tern (Table 4).
In biphasic pattern group were significantly more pa-
tients with MACE positive vs. MACE negative; biphasic
pattern (25 pts) vs. monophasic pattern (8 pts), signifi-
cance of p<0.001 (Table 5).
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TABLE 3
CORRELATION OF AMI ALLOCATIONS TO BNP PATTERNS
AMI allocation Anteroseptolat. Other allocat.
Monophasic (n=44) 1 (2.27%) 43 (97.92%)
Biphasic (n=31) 14 (45.17%) 17 (54.83%)
TABLE 4
BNP PATTERNS IN HEART FAILURE



















PATTERN OF RELEASE COMPARED TO MACE














MACE (major adverse cardiac events)
TABLE 2
BNP IN MONOPHASIC AND BIPHASIC PATTERN OF RELEASE
Pattern of
BNP release
BNP 1 (pg/mL) BNP 2 (pg/mL)
Monophasic Biphasic Monophasic Biphasic
X 278.44 706.23 221.23 883.97
SD 208.14 554.69 123.02 472.90
SEM 31.37 99.62 18.54 84.93
Median 210.94 588.34 198.18 671.54




BNP 1 (first measurement in the 1st to 2nd day of admission)
BNP 2 (second measurement in the 5th to 8th day of admission)
TABLE 6
PATTERN OF BNP RELEASE COMPARED TO LV REMODELLING















In biphasic pattern group were significantly more pa-
tients with LV remodelling; biphasic pattern (17 pts) vs.
monophasic pattern (2 pts), significance of p<0.001 (Ta-
ble 6).
Discussion
In patients with acute myocardial infarction BNP lev-
els are significantly higher compared to controls. Recent
studies explained that BNP in AMI was released not only
due to systolic dysfunction, it seems that ischaemia per se
induces its release5,6,12,13.
We found inverse proportional correlation between
BNP level and LVEF, correlation test demonstrated sta-
tistically significant real negative correlation with high
coefficient of correlation (r=–0.684). This makes BNP as
unique biochemical marker of systolic dysfunction of left
ventricle what is consistent with study of Groenning et
al.2 and Mega et al.8.
BNP concentrations were significantly higher among
patients in Killip class II compared to Killip class I, while
BNP concentration in patients with Killip class III were
significantly higher compared to Killip class II (Killip I
226.18 pg/mL vs. Killip II 622.51 pg/mL vs. Killip III
1530.28 pg/mL, p<0.001), and it is clear that BNP in-
creases in a graded manner. Our results are similar to re-
sults in recent studies6,14–16.
Measuring BNP concentration we can estimate stage
of heart failure or diagnose it even when patient is
asymptomatic or when typical signs of heart failure are
absent3,15.
Brain natriuretic peptide levels were higher among
patients with MACE (major adverse cardiac events: an-
gina, reinfarction, heart failure, ventricular arrhythmias,
sudden cardiac death) (779.08 pg/mL vs. 242.28 pg/mL,
p<0.001). Our results are consistent with works of Rich-
ards et al.14 who found BNP not only as a prognostic
marker of LVEF but also predictor of new ischaemic
events as well as future hospitalisation due to heart fail-
ure and mortality even in Killip class I group of patients.
BNP levels were significantly higher among patients
with LV remodelling (840.77 pg/mL vs. 341.41 pg/mL,
p<0.001), promoting BNP as an early biochemical pre-
dictor of LV remodelling.
In patients who died during hospitalisation BNP levels
were significantly higher compared to survivors (1694.33
vs. 478.47 pg/mL, p<0.01). According to de Lemos et al.7
higher BNP levels in prediction of mortality are not only
consequence of systolic dysfunction but also reflect seve-
rity of ischaemia.
In AMI it is important to do risk stratification and es-
pecially to identify »high« risk patients for future MACE
events. Study of Jernberg15 proves a benefit of early inva-
sive management in patients with highest tercils of BNP
level.
According to BNP levels now it is possible to profile
»low« and »high« risk patient and make a decision about
conservative or invasive management15.
Group with biphasic pattern of BNP release has sig-
nificantly higher BNP concentration in first and second
measurements vs. monophasic pattern. In biphasic pat-
tern group were significantly more patients with lower
LVEF, anteroseptolateral AMI, Killip class II and Killip
class III, LV remodelling and MACE.
First peak in BNP secretion is due to myocardial ne-
crosis and its release from necrotic myocites. It is sus-
pected that second peak is due to expansion of infarction,
systolic dysfunction and subsequent remodelling of LV.
Ischaemia in second peak-patients with biphasic pattern
leads to worse prognosis due to more severe coronary
heart disease15.
Goetze16 define BNP as »an intermedium between
coronary artery disease and heart failure giving informa-
tion of critical importance in identification of »low risk«
and »high risk« patients«.
Conclusion
In conclusion, we found that BNP is strong marker of
adverse cardiac events in patients presenting with a
myocardial infarction. BNP levels are elevated in AMI
and its rise is proportional to decrease of LVEF. BNP rise
is proportional to severity of heart failure but it is also
predictor of left ventricular remodelling, MACE and mor-
tality. BNP in AMI is important prognostic marker for
future post infarction left ventricle function, morbidity
and mortality.
Biphasic pattern of BNP release is associated with high-
er BNP levels, lower LVEF, Killip class II and Killip class
III, higher incidence of MACE and ventricular remodel-
ling. First peak in BNP secretion is due to myocardial ne-
crosis and its release from necrotic myocites. Patients
with biphasic pattern probably have worse prognosis due
to more severe coronary heart disease.
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DVOFAZNI I JEDNOFAZNI UZORAK LU^ENJA MO@DANOG NATRIURETSKOG PEPTIDA
U AKUTNOM INFARKTU MIOKARDA
S A @ E T A K
Studija je istra`ivala lu~enje mo`danog natriuretskog peptide (brain natriuretic peptide – BNP) kod pacijenata sa
akutnim infarktom miokarda (acute myocardial infarction – AMI), i to njegove apsolutne vrijednosti, kao i uzorke
lu~enja. Postoje dva razli~ita uzorka lu~enja BNP u akutnom infarktu miokarda; jednofazni – koncentracija u prvom
mjerenju je ve}a nego u drugom, i dvofazni – koncentracija u prvom mjerenju je ni`a u odnosu na drugo mjerenje. Pro-
matrali smo zna~ajnost jednofaznog i dvofaznog uzorka lu~enja BNP u odnosu na njegovu dijagnosti~ku i prognosti~ku
vrijednost. U prospektivnu observacionu studiju uklju~ili smo ukupno 75 pacijenata sa AMI, 52 mu{karca i 23 `ene,
srednje starosne dobi od 62,3±10,9, u rasponu od 42 do 79 godina. Promatrana je vrijednost BNP kao i uzorak lu~enja.
U AMI grupi vrijednost BNP bila je statisti~ki zna~ajno ve}a u odnosu na kontrolnu skupinu pacijenata (462,88 pg/mL
vs. 35,36 pg/mL, p<0,001). Utvrdili smo statisti~ki zna~ajnu negativnu korelaciju (p<0,05) vrijednosti BNP prema is-
tisnoj frakciji lijeve klijetke (left ventricular ejection fraction – LVEF) sa visokim koeficijentom korelacije (r=–0,684).
Vrijednosti BNP bile su zna~ajno vi{e kod pacijenata sa sr~anom slabosti Killip klase II i III, pore|eno sa Killip klasom I;
Killip klasa I BNP=226.18 pg/mL vs. Killip klasa II 622.51 pg/mL vs. Killip klasa III 1530.28 pg/mL, p<0.001. Vrijedno-
sti BNP bile su zna~ajno vi{e kod pacijenata sa; (i) infarktom miokarda prema kontrolnoj skupini (BNP 835,80 pg/mL
vs. 243,03 pg/mL), (ii) kod pacijenata sa prisutnim zna~ajnim nepovoljnim sr~anim doga|ajima (major adverse cardiac
events – MACE) prema pacijentima bez MACE (BNP 779,08 pg/mL vs. 242,28 pg/mL, p<0,001); (iii) kod pacijenata sa
prisutnim preoblikovanjem lijeve klijetke (left ventricular remodelling) u odnosu na pacijente bez preoblikovanja lijeve
klijetke (BNP 840,77 pg/mL vs. 341,41 pg/mL, p<0,001). Grupa pacijenata sa dvofaznim uzorkom lu~enja BNP imala je
zna~ajno ve}u vrijednost BNP u odnosu na grupu pacijenata sa jednofaznim uzorkom BNP lu~enja. Kod dvofaznog
lu~enja na{li smo statisti~ki zna~ajnu prisutnost sni`ene istisne frakcije lijeve klijetke (LVEF), zatim sr~ane slabosti
Killip klase II i III, zatim preoblikovanja lijeve klijetke, i zna~ajnih nepovoljnih sr~anih doga|aja (MACE). U na{em
istra`ivanju utvrdili smo da je BNP statisti~ki zna~ajan pokazatelj nepovoljnih sr~anih doga|aja kod pacijenata sa akut-
nim infarktom miokarda. U AMI grupi pacijenata zna~ajno su bile pove}ane vrijednosti BNP i smatra se da drugi vrh
lu~enja nije samo vezan za sistoli~ku disfunkciju kao i posljedi~no preoblikovanje lijeve klijetke, nego i za prisutnu ishe-
miju. Pacijenti sa dvofaznim uzorkom lu~enja vjerovatno imaju lo{iju prognozu {to je u vezi sa te{kom sr~anom koro-
narnom bolesti. Pored dijagnosti~ke uloge odre|ivanja BNP, kao jednostavnog pokazatelja sistoli~ke funkcije, BNP je
tako|er va`an prognosti~ki pokazatelj koji poma`e kod dono{enja odluke o odabiru izme|u ranog invazivnog ili stan-
dardnog konzervativnog lije~enja.
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